|

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

RECRUITINGN/ASponsored by Roswell Park Cancer Institute
Actively Recruiting
PhaseN/A
SponsorRoswell Park Cancer Institute
Started2025-04-21
Est. completion2030-03-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This clinical trial studies whether a post-treatment supportive service program can be used to help breast cancer survivors in Western New York (WNY) transition into post-treatment life (survivorship). The post-treatment supportive service program is delivered to breast cancer survivors of WNY. It combines group support sessions and one-on-one (1:1) peer mentoring sessions. The group support sessions include traditional support groups, educational topics/lessons, activities, such as cooking lessons, celebrations, or facility tours, and guest speakers. The 1:1 peer mentoring sessions are held with a long-term breast cancer survivor mentor. The long-term breast cancer survivor mentor helps the mentee get in the practice of performing once monthly self-assessments and create plans to help improve any identified modifiable risk factors. The long-term breast cancer survivor mentor can also help connect the mentee to providers or resources as needed. A post-treatment supportive service program may help Black women breast cancer survivors in WNY transition into survivorship.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Ability to speak and read English
* At least 18 years of age or older
* Live in the Western New York area
* Has been diagnosed with breast cancer (any stage)
* Has completed primary breast cancer treatments (i.e., systemic, radiation, and/or surgical interventions other than breast reconstruction surgeries)

  * Mentors are at least one-year post-treatment completion
  * Mentees are less than one-year post-treatment completion
  * Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)

    * Note: Although any breast cancer survivor may participate, priority will be given to those who have most recently transitioned into their post-treatment life (or those who report that support was either not offered or was unavailable to them during their less recent transition into post-treatment life) and /or self-identify as African American

Exclusion Criteria:

* Currently receiving neoadjuvant and/or adjuvant systemic and/or radiations therapies
* Unwilling or unable to complete the assessment in English
* Are pregnant or nursing
* Are unwilling or unable to follow protocol requirements

  * Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)

Conditions3

Breast CancerBreast CarcinomaCancer

Locations1 site

Roswell Park Cancer Institute
Buffalo, New York, 14263
Julia Devonish716-845-2300julia.devonish@roswellpark.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.